GSK1370319A (GSK-1370319A) is a novel and potent P2X7 antagonist with IC50 of 3.2 nM. It would raise the hope for a cure to many P2X7-dependent pathologies, including inflammatory, neurological, and immune diseases.

纯度：≥98%

CAS：1001389-31-6